MAHL.Y Stock Overview
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
MediPal Holdings Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥15.90 |
| 52 Week High | JP¥19.07 |
| 52 Week Low | JP¥14.29 |
| Beta | 0 |
| 11 Month Change | -12.88% |
| 3 Month Change | n/a |
| 1 Year Change | 0.60% |
| 33 Year Change | -9.66% |
| 5 Year Change | -26.90% |
| Change since IPO | 36.25% |
Recent News & Updates
Recent updates
Shareholder Returns
| MAHL.Y | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 2.0% | 1.6% |
| 1Y | 0.6% | 7.5% | 32.3% |
Return vs Industry: MAHL.Y underperformed the US Healthcare industry which returned 7.5% over the past year.
Return vs Market: MAHL.Y underperformed the US Market which returned 32.3% over the past year.
Price Volatility
| MAHL.Y volatility | |
|---|---|
| MAHL.Y Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MAHL.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MAHL.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1898 | 13,075 | Shuichi Watanabe | www.medipal.co.jp |
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products.
MediPal Holdings Corporation Fundamentals Summary
| MAHL.Y fundamental statistics | |
|---|---|
| Market cap | US$3.29b |
| Earnings (TTM) | US$304.75m |
| Revenue (TTM) | US$23.86b |
10.8x
P/E Ratio0.1x
P/S RatioIs MAHL.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MAHL.Y income statement (TTM) | |
|---|---|
| Revenue | JP¥3.60t |
| Cost of Revenue | JP¥3.35t |
| Gross Profit | JP¥251.72b |
| Other Expenses | JP¥205.67b |
| Earnings | JP¥46.05b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 221.43 |
| Gross Margin | 6.98% |
| Net Profit Margin | 1.28% |
| Debt/Equity Ratio | 0% |
How did MAHL.Y perform over the long term?
See historical performance and comparison